Call Options

20 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$23.37 - $28.68 $170,601 - $209,364
7,300 Added 169.77%
11,600 $321,000
Q3 2023

Nov 14, 2023

SELL
$27.17 - $31.97 $163,020 - $191,820
-6,000 Reduced 58.25%
4,300 $120,000
Q2 2023

Aug 14, 2023

SELL
$28.34 - $33.63 $629,148 - $746,586
-22,200 Reduced 68.31%
10,300 $322,000
Q1 2023

May 15, 2023

BUY
$25.31 - $29.02 $822,575 - $943,150
32,500 New
32,500 $916,000
Q2 2022

Aug 08, 2022

SELL
$26.4 - $30.54 $955,680 - $1.11 Million
-36,200 Reduced 97.05%
1,100 $33,000
Q1 2022

May 16, 2022

BUY
$23.07 - $27.99 $452,172 - $548,604
19,600 Added 110.73%
37,300 $981,000
Q4 2021

Feb 14, 2022

BUY
$21.47 - $32.08 $307,021 - $458,744
14,300 Added 420.59%
17,700 $412,000
Q3 2021

Nov 15, 2021

BUY
$23.37 - $32.13 $79,458 - $109,242
3,400 New
3,400 $105,000
Q1 2021

May 17, 2021

SELL
$18.21 - $23.2 $87,408 - $111,360
-4,800 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$15.39 - $22.1 $156,978 - $225,420
-10,200 Reduced 68.0%
4,800 $96,000
Q3 2020

Nov 16, 2020

SELL
$16.16 - $20.66 $505,808 - $646,658
-31,300 Reduced 67.6%
15,000 $249,000
Q2 2020

Aug 14, 2020

BUY
$13.31 - $19.41 $292,820 - $427,020
22,000 Added 90.53%
46,300 $898,000
Q1 2020

May 15, 2020

BUY
$13.06 - $21.24 $181,534 - $295,236
13,900 Added 133.65%
24,300 $350,000
Q4 2019

Feb 14, 2020

BUY
$17.29 - $21.74 $74,347 - $93,482
4,300 Added 70.49%
10,400 $212,000
Q3 2019

Nov 14, 2019

SELL
$19.51 - $24.28 $411,661 - $512,308
-21,100 Reduced 77.57%
6,100 $119,000
Q2 2019

Aug 14, 2019

BUY
$21.47 - $37.33 $264,081 - $459,159
12,300 Added 82.55%
27,200 $613,000
Q1 2019

May 15, 2019

SELL
$28.4 - $36.49 $1.06 Million - $1.36 Million
-37,300 Reduced 71.46%
14,900 $544,000
Q4 2018

Feb 14, 2019

BUY
$27.94 - $44.61 $1.28 Million - $2.04 Million
45,700 Added 703.08%
52,200 $1.54 Million
Q3 2018

Nov 14, 2018

SELL
$38.6 - $46.12 $34,740 - $41,508
-900 Reduced 12.16%
6,500 $276,000
Q2 2018

Aug 14, 2018

BUY
$40.56 - $51.36 $300,144 - $380,064
7,400 New
7,400 $305,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.8B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.